Navigation Links
Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
Date:4/3/2011

a composite of death, myocardial infarction (MI), urgent target vessel revascularization (TVR) or recurrent ischemia at 30 days.  

Previously presented data from RADAR (AHA, November 2010) confirmed that pegnivacogin dosed at 1mg/kg reproducibly resulted in near complete inhibition of FIXa in an ACS population.  The latest RADAR results showed that ACUITY major bleeding following immediate sheath removal exhibited a dose response with bleeding rates decreasing with increasing levels of reversal.  Rates of bleeding were lower in the 75% and 100% reversal arms than heparin.  In addition, the incidence of ischemic events was lower in REG1 treated patients compared with those treated with heparin.  

Adverse events (AEs) other than bleeding and ischemic events were rare and evenly distributed among the arms of the study.  Three patients, clustered late in the trial and in Europe, had allergic-like reactions shortly after receiving pegnivacogin.  Characterization of these reactions is ongoing.  

"We are thrilled by the results of RADAR and the groundbreaking advance in anticoagulant therapy that they foretell.  It is now clear that control matters.  REG1 uniquely has shown the promise of simultaneously reducing ischemia and bleeding in comparison to heparin," said Dr. David J. Mazzo, President and CEO of Regado Biosciences, Inc.  He added, "The results of the RADAR trial solidly support Phase 3 development of REG1 in the broader ACS population.  Regado plans to move forward in this indication as well as in a parallel indication of open heart surgery."  

"The Phase 2b RADAR results suggest that high intensity FIXa inhibition with active control may ultimately represent a potential treatment option for addressing both ischemic and bleeding endpoints for patients who require short term anticoagulation in acute care settings," said John H. Alexander, MD, MHS, FACC of the Duke Clinica
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
2. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
3. Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
4. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
5. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
6. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
7. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
8. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
9. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
10. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
11. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine ... methamphetamine offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... NEW YORK , Aug. 20, ... a new market research report is ... The Market for Hospital-Acquired Infection Control ... http://www.reportlinker.com/p01618925/The-Market-for-Hospital-Acquired-Infection-Control-Sterilization-Disinfection-Testing-and-Treatment.html ... and healthcare-associated infections (HAIs), demand has ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6
... GenVec, Inc. (Nasdaq: GNVC ) announced today that ... Research (SBIR) grant from the National Cancer Institute (NCI) of ... of a new approach to treating metastatic cancer. Under this ... that the delivery of a specific gene will stimulate an ...
... , PITTSBURGH, Sept. 30 ThermalTherapeutic Systems, Inc., ... standardize hyperthermic perfusion announced today the completion of ... After receiving initial start-up funding by the Pittsburgh ... financing which included follow-on investments by the Pittsburgh ...
Cached Medicine Technology:GenVec Receives National Cancer Institute Grant to Expand Cancer Program 2ThermalTherapeutic Systems Completes $2.75 Million Series A Financing With Originate Ventures 2
(Date:8/21/2014)... The costs paid by consumers each year for dental ... data. The Quotes Pros company is now helping American families ... at http://quotespros.com . , The automatic policy finder ... offering multiple coverage packages for dental related care this year. ... now easier to compare using the all-in-one digital system. ...
(Date:8/21/2014)... 21, 2014 Pack Expo is ... and Processing Technologies. They deliver the industry’s best ... a whole new world of advancement and opportunity. ... education, and the latest technology and innovations in ... This year at Pack Expo International, 50,000 attendees ...
(Date:8/21/2014)... 22, 2014 Top10BestSEOHosting.com has recently ... that iPage ( http://www.top10bestseohosting.com/go/iPage/ ) is one of ... , The manager of Top10BestSEOHosting.com states, “It ... supplier. Actually, these companies have outperformed their competitors ... support. People can get the best web hosting ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 The costs for maintaining ... two decades, according to new insurance industry studies. The Quotes Pros ... finder to locate affordable plans from all 50 states at ... more than $50 for a routine visit or complex surgery can ... Every user of the system will be asked to provide a ...
(Date:8/21/2014)... 2014 BambooIndustry.com is an internationally well-known ... has recently unveiled its new collection of elegant ... for customers who are looking for high quality floorings ... offered with great savings (up to 29 percent off). ... these cheap products. , The company’s bamboo flooring ...
Breaking Medicine News(10 mins):Health News:Dental Insurance Now Quoted for Families Online at Insurer Portal 2Health News:Absolute I&D Provides Discounted Labor for Pack Expo Chicago 2Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Pet Insurance Finder for 50 States Launched at Insurance Website Online 2Health News:Buy Elegant Bamboo Floorings from Internationally Well-known Supplier BambooIndustry.com 2
... Contract supports U.S. Army,s Stryker medical evacuation vehicle, ... AIRM ), the largest air medical transportation ... has been awarded a contract in,excess of $15 ... for Air Methods to provide more than 300 ...
... Oct. 27 New research published in the ... because the,fruit possesses antimicrobial phytochemicals that suppress growth ... gum disease. The study,was conducted at the College ... a research group led by Christine D. Wu, ...
... 6:00 am PST -- UCB announced,today the ... Research,and Education Foundation (REF) as a Pinnacle sponsor ... for Rheumatoid Arthritis." The,announcement was made at the ... are joining the Within Our Reach program because ...
... review finds it,s an accepted treatment in adults as ... -- Between 1990 and 2002, off-label use of anticancer ... and 33.2 percent, and most of that off-label use ... studies from a number of countries. , In off-label ...
... DALLAS, Oct. 27 From Illinois to California, ... (Connecting About,Real Experiences) to find out about patients, ... visit. Hospitals participating in the initial,launch of this ... IL;,Clovis Community Medical Center in Clovis, CA; HealthONE ...
... ARAY ), a global leader in the field ... present at the 19th,Annual Oppenheimer Healthcare Conference in New ... (7:00 a.m. PST.), A live webcast of the ... of the Company,s Web site at, http://www.accuray.com . The ...
Cached Medicine News:Health News:Air Methods Awarded $15 Million Contract From General Dynamics Land Systems 2Health News:University of Illinois - Chicago Study: Raisins Contain Compounds that May Inhibit Cavity-causing Bacteria 2Health News:UCB Becomes Pinnacle Donor to the American College of Rheumatology Research and Education Foundation's Research Campaign 2Health News:UCB Becomes Pinnacle Donor to the American College of Rheumatology Research and Education Foundation's Research Campaign 3Health News:Most Off-Label Cancer Drug Use for Palliative Care 2Health News:The Beryl Companies Launches CARE Calls Program in Five Hospitals Across U.S. 2Health News:Accuray Incorporated to Speak at Oppenheimer Healthcare Conference 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: